These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 19264885)
41. Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a. Zaniolo K; Sapieha P; Shao Z; Stahl A; Zhu T; Tremblay S; Picard E; Madaan A; Blais M; Lachapelle P; Mancini J; Hardy P; Smith LE; Ong H; Chemtob S Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5376-86. PubMed ID: 21642627 [TBL] [Abstract][Full Text] [Related]
42. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization. Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610 [TBL] [Abstract][Full Text] [Related]
43. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase. Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296 [TBL] [Abstract][Full Text] [Related]
44. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987 [TBL] [Abstract][Full Text] [Related]
45. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Wang X; Wang G; Wang Y Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381 [TBL] [Abstract][Full Text] [Related]
46. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat. van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314 [TBL] [Abstract][Full Text] [Related]
47. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157 [TBL] [Abstract][Full Text] [Related]
48. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression. Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435 [TBL] [Abstract][Full Text] [Related]
49. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α. Han N; Xu H; Yu N; Wu Y; Yu L Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201 [TBL] [Abstract][Full Text] [Related]
50. [Role of chemokines in the vitreous of proliferative diabetic retinopathy]. Kawashima M; Shoji J; Kamura Y; Sato Y Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):596-602. PubMed ID: 16218438 [TBL] [Abstract][Full Text] [Related]
51. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina. Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026 [TBL] [Abstract][Full Text] [Related]
52. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment. Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182 [TBL] [Abstract][Full Text] [Related]
53. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy. Lu Q; Lu L; Chen W; Lu P Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825 [TBL] [Abstract][Full Text] [Related]
54. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012 [TBL] [Abstract][Full Text] [Related]
55. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062 [TBL] [Abstract][Full Text] [Related]
56. Captopril and vascular endothelial growth factor in a mouse model of retinopathy. Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165 [TBL] [Abstract][Full Text] [Related]
57. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Yoshida S; Murata M; Noda K; Matsuda T; Saito M; Saito W; Kanda A; Ishida S Jpn J Ophthalmol; 2018 Mar; 62(2):256-264. PubMed ID: 29392528 [TBL] [Abstract][Full Text] [Related]
58. Remodeling retinal neovascularization by ALK1 gene transfection in vitro. Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861 [TBL] [Abstract][Full Text] [Related]
59. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy. Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127 [TBL] [Abstract][Full Text] [Related]
60. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]